Your browser doesn't support javascript.
loading
Paroxysmal nocturnal hemoglobinuria clone in 103 Brazilian patients: diagnosis and classification
Azambuja, Ana Paula de; Malvezzi, Mariester; Bitencourt, Marco Antonio; Oliveira, Michel Michels; Medeiros, Larissa Alessandra; Pasquini, Ricardo.
  • Azambuja, Ana Paula de; Universidade Federal do Paraná. Curitiba. BR
  • Malvezzi, Mariester; Universidade Federal do Paraná. Curitiba. BR
  • Bitencourt, Marco Antonio; Universidade Federal do Paraná. Curitiba. BR
  • Oliveira, Michel Michels; Universidade Federal do Paraná. Curitiba. BR
  • Medeiros, Larissa Alessandra; Universidade Federal do Paraná. Curitiba. BR
  • Pasquini, Ricardo; Universidade Federal do Paraná. Curitiba. BR
Rev. bras. hematol. hemoter ; 37(2): 90-97, Mar-Apr/2015. tab, graf
Article in English | LILACS | ID: lil-746093
ABSTRACT

Background:

Paroxysmal nocturnal hemoglobinuria is an acquired chronic hemolytic ane- mia, which often manifests as peripheral blood cytopenias and thrombosis.

Objective:

The aim of this study is to describe a Brazilian population of paroxysmal nocturnal hemoglobinuria patients.

Methods:

One hundred and three paroxysmal nocturnal hemoglobinuria cases were retrospectively reviewed and the clinical presentation, thrombosis, survival, and clone size were assessed. Diagnosis was established by flow cytometry.

Results:

Fifty-two male and 51 female patients with a median age of 24.1 years (5.5-62 years) were studied. Clinical symptoms included hemoglobinuria (18.4%), infection (46.6%) and thrombosis (16.5%), and 80.6% had pancytopenia. Patients were classified as classic parox- ysmal nocturnal hemoglobinuria (10), paroxysmal nocturnal hemoglobinuria with aplastic anemia (39), and paroxysmal nocturnal hemoglobinuria with subclinical features and aplas- tic anemia (54). There were significant differences in terms of median age, size of clone, clinical symptoms, and peripheral blood cell counts between the three subcategories. The clone size in erythrocytes and granulocytes were respectively 0.04% (range 0-18%) and 7.3% (range 0.3-68.7%) in patients with subclinical features and aplastic anemia, 15.8% (range 0-99.7%) and 63.0% (range 1.7-99.8%) in patients with aplastic anemia alone, and 82.2% (range 0-99.85%) and 98.0% (81.3-100.0%) in Classic disease. Statistical differences were identified for platelets (p-value = 0.001), lactate dehydrogenase (p-value = 0.002) and the clone size (p-value < 0.001) in patients who suffered thrombotic events compared to those who did not. Overall survival was 81.7%, with patients with subclinical features and aplastic anemia having lower overall survival (76.5%).

Conclusion:

This retrospective review of 103 patients over an 11-year period represents the largest collection of paroxysmal...
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Bone Marrow / Flow Cytometry / Hemoglobinuria, Paroxysmal Type of study: Diagnostic study Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Rev. bras. hematol. hemoter Journal subject: Hematology Year: 2015 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal do Paraná/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Bone Marrow / Flow Cytometry / Hemoglobinuria, Paroxysmal Type of study: Diagnostic study Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Rev. bras. hematol. hemoter Journal subject: Hematology Year: 2015 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal do Paraná/BR